APA (7th ed.) Citation

Khosravan, R., Grabowski, B. A., Wu, J., Joseph-Ridge, N., & Vernillet, L. (2006). Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects. Clinical pharmacokinetics, 45(8), 821-841. https://doi.org/10.2165/00003088-200645080-00005

Chicago Style (17th ed.) Citation

Khosravan, Reza, Brian A. Grabowski, Jing-Tao Wu, Nancy Joseph-Ridge, and Laurent Vernillet. "Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects." Clinical Pharmacokinetics 45, no. 8 (2006): 821-841. https://doi.org/10.2165/00003088-200645080-00005.

MLA (9th ed.) Citation

Khosravan, Reza, et al. "Pharmacokinetics, Pharmacodynamics and Safety of Febuxostat, a Non-Purine Selective Inhibitor of Xanthine Oxidase, in a Dose Escalation Study in Healthy Subjects." Clinical Pharmacokinetics, vol. 45, no. 8, 2006, pp. 821-841, https://doi.org/10.2165/00003088-200645080-00005.